News

Article

BMS Sell API Facility to SK Biotek

SK Biotek plans to operate the Swords, Ireland API manufacturing facility as a contract development and manufacturing site.

SK Biotek Co., Ltd, a wholly-owned subsidiary of SK Holdings, will be the first Korean company to invest in pharmaceutical manufacturing in Ireland with the announced acquisition of the Bristol-Myers Squibb’s small-molecule API manufacturing facility in Swords, Ireland. The companies announced the acquisition in a June 16, 2017 statement.

The companies have an existing pharmaceutical manufacturing and supply relationship; SK Biotek has produced commercial API starting materials and chemical intermediates for BMS.

The Swords facility manufactures APIs for medicines including Bristol-Myers Squibb’s and Pfizer’s Eliquis. SK Biotek announced plans to operate the plant as a contract development manufacturing organization (CDMO), add marketing and R&D staff, and invest in additional capacity.

“This transaction is an important step to achieve our goal of becoming a leading global CDMO.” Junku Park, chief executive officer of SK Biotek, commented in the statement. “It allows us to enhance technological and manufacturing capacity and build long-term partnerships with existing and new customers. We have chosen to invest in Ireland because of the welcoming business environment and the exceptionally talented workforce, and we look forward to growing our presence in Swords in the coming years. We are very pleased to welcome the Swords facility to SK Biotek.”

Bristol-Myers Squibb and SK Biotek anticipate that the transaction will close during the fourth quarter of 2017, subject to certain environmental permits and other customary closing conditions. The transaction has been approved by the boards of directors of both companies.

Source: Bristol-Myers Squibb

 

 

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More
Related Content